Principles for the Use of Funds From the Opioid Litigation
Developed by a coalition of organizations across the spectrum of the substance use field including physicians, addiction medicine specialists, recovery, treatment, and harm reduction. The Principles for the Use of Funds From the Opioid Litigation provide planning and process level guidance for state and local policymakers.
Implementing the Principles
Tools and Resources to assist in Implementing the Principles
For specific guidance for state and local jurisdictions on how to spend their portion of the litigation dollars, these supplemental documents can help assess and guide your planning process and spending allocation.
Implications for the Opioid Overdose Crisis
Over 500,000 people have died from opioid overdoses since 1999. Unfortunately, the crisis has worsened during the COVID-19 pandemic. An estimated 106,000 people died from opioid overdoses in 2020, more than in any other year. Fortunately, states and local jurisdictions will soon have additional money to invest in evidence-based solutions as a result of litigation brought against opioid manufactures, distributors and dispensers.
In the Media
Purdue Pharma Is Dissolved and Sacklers Pay $4.5 Billion to Settle Opioid Claims
The ruling in bankruptcy court caps a long legal battle over the fate of a company accused of fueling the opioid epidemic and the family that owns it.
Statement from Public Health Experts on Announcement of Opioid Settlement
Reaction to the announcement of the $26 billion settlement deal between a group of state attorneys general and Cardinal Health, AmerisourceBergen, McKesson, and Johnson & Johnson.
COVID Dollars, Best Practices Arm Communities with New Weapons Against Drug-Overdose Scourge
Federal spending to address substance use disorders and mental illness is increasing by around 25%. It is a once-in-a-generation opportunity to improve our response to substance use disorders, but it also challenges us to spend the money wisely.